Related Experiment Video
Updated: Jul 13, 2026
12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
Rapid communication: robot-assisted anterior exenteration: technique and initial series
Khurshid A Guru1, Mark Nogueira, Pamela Piacente
1Department of Urologic Oncology, Roswell Park Cancer Institute, Buffalo, New York14263, USA. khurshid.guru@roswellpark.org
Journal of Endourology
|July 20, 2007
Summary
Robot-assisted anterior exenteration (RAAE) is a safe procedure for women with bladder cancer, showing promising perioperative and oncologic outcomes. Further research will establish its long-term role in urologic oncology.
Area of Science:
- Urology
- Surgical Oncology
- Robotic Surgery
Background:
- Robot-assisted anterior exenteration (RAAE) feasibility in women requires further establishment.
- Previous reports on RAAE are limited, necessitating more clinical experience.
Purpose of the Study:
- To evaluate the feasibility and outcomes of robot-assisted anterior exenteration (RAAE) in female patients with bladder cancer.
- To provide perioperative data, hospital course, and immediate oncologic outcomes for RAAE.
Main Methods:
- Seven female patients with bladder cancer underwent robot-assisted anterior exenteration (RAAE).
- Data collected prospectively included operative times, intraoperative events, postoperative complications, and oncologic status.
- Urinary diversion involved ileal conduit in six patients and neobladder in one.
Main Results:
- No intraoperative complications or blood transfusions were required; no cases were converted to open surgery.
- The only postoperative complication was a successfully managed pyelonephritis.
- Six of seven patients achieved negative surgical margins, with a mean return to strenuous activity at 7.3 weeks.
Conclusions:
- Robot-assisted anterior exenteration (RAAE) can be safely performed in women.
- The long-term oncologic efficacy and broader adoption of RAAE depend on future studies and collective experience.
